Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines
If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the costs of some of the drugs on the market today.
If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the costs of some of the drugs on the market today.
A new and sizable report from Credit Suisse highlights the firm's top picks for 2015. We scanned through them looking for the stocks with the biggest upside to the Credit Suisse price targets.
In a new report from UBS, the analysts take an in-depth look at the growing yieldco space, where they think dividends may grow exponentially for years to come.
Three top Internet stocks are set to report this week, and a new research report from Cowen handicaps the results.
The RBC Top Picks list has done outstanding since its inception at the end of 2011 by handily outperforming the S&P 500 and bringing alpha value to the firm's customers.
Some of these battered tech names may make good additions to a portfolio as they pay decent dividends, should continue to buy stock back and should turn around the underperforming company segments as the…
Here are the five biotech stocks that are loved the most by portfolio managers, according to Cowen analysts.
A new Deutsche Bank report highlights some of the firm's favorite domestic stocks to buy now. All of them do either 100% of business in the United States or very close to it.
A new report from J.P. Morgan suggests that the collapse in crude oil prices is lifting growth, both here and abroad. Not only are the top retail companies poised to benefit, but so are…
The IT hardware analysts at UBS point out that none of their top stocks to buy are currently overbought. These five stocks to buy now present solid value for investors.
A new research note from RBC points out that when looking at stock valuations from a dividend perspective, stocks have not been this cheap in the 15 years.
Nothing gets insiders and owners of stock a little nervous more than markets trading near all-time highs, and volatility starting to rear its ugly head.
With volatility spiking much higher than last year, one thing that bodes well for equity investors is the number of insiders that continue to add to their holdings.
Obviously the overall market has been in a topsy-turvy mode for most of the January trading days, and earnings for the most part have been good, but very mixed.
The whole week has been one train-wreck after another for some of the top technology stocks. Not just marginal players have been stung, but market share leaders have been taken to the woodshed.
In a new research note from Jefferies, five top tech companies are standouts in the firm's coverage universe.
In an energy sector that has struggled, the refiners have shined, and Cowen analysts are focused on six top stocks to buy.
A new research note from the quantitative strategies team at Jefferies highlights the top buys and sells for the Russell 1000 and Russell 2000. These five companies will see the most shares bought on…
Here are five stocks rated Outperform at Baird that are seeing a high percentage of pulmonary Medicare admissions.
Here are five applied technologies stocks rated Underperform now at J.P. Morgan, with some of the firm's rationale on why they are.